ArticleLipids in health and disease2025
Association of the triglyceride glucose-body roundness index with mortality in HFpEF and effect modification by nutritional status: a multicenter prospective cohort study.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart failure with preserved ejection fraction (HFpEF) is a major cause of morbidity and mortality. Insulin resistance and visceral adiposity play pivotal roles in its pathogenesis; however, the prognostic significance of the triglyceride glucose-body roundness index (TyG-BRI) and its interaction with nutritional status remain uncertain.
methodsA total of 1,015 patients with HFpEF were prospectively enrolled. The TyG-BRI was calculated as the product of the triglyceride-glucose index (TyG index) and the body roundness index (BRI). Cox regression models were used to evaluate its prognostic value for adverse outcomes, with subgroup analyses stratified by nutritional status and mediation analysis assessing the role of exercise tolerance.
resultsDuring follow-up, 232 (22.9%) all-cause and 158 (15.6%) cardiovascular (CV) deaths occurred. In multivariate Cox regression analysis, patients in the highest TyG-BRI tertile exhibited significantly higher risks of all-cause (hazard ratio [HR] = 2.59, 95% confidence interval [CI]: 1.82-3.71; P for trend < 0.001) and CV mortality (HR = 2.43, 95% CI: 1.59-3.72; P for trend < 0.001) compared with those in the lowest tertile. The prognostic value of the TyG-BRI for all-cause mortality was more prominent among participants with impaired nutritional status (malnourished or at risk of malnutrition) (P for interaction < 0.1). Incorporation of the TyG-BRI into the baseline risk model for all-cause death significantly improved model discrimination (C-statistic = 0.701 vs. 0.626; P < 0.001) and outperformed its individual components (P < 0.05). Mediation analysis further revealed that the six-minute walk distance mediated 14.6% of the association between the TyG-BRI and all-cause mortality.
conclusionsIn patients with HFpEF, the TyG-BRI was independently associated with adverse outcomes, with its prognostic value particularly evident among those with impaired nutritional status. Incorporating the TyG-BRI into the risk model modestly improved prognostic discrimination, and reduced exercise capacity appeared to partly mediate this association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.